• Search History (Register)
  • MeSH Browser
  • [Clear]
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Canada
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [3321 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2013     Health Quality Ontario (HQO) Self-management support interventions for persons with chronic disease: an evidence-based analysis
2013     Health Quality Ontario (HQO) Specialized nursing practice for chronic disease management in the primary-care setting: an evidence-based analysis
2013     Health Quality Ontario (HQO) Electronic tools for health information exchange: an evidence-based analysis
2013     Health Quality Ontario (HQO) Health technologies for the improvement of chronic disease management: a review of the Medical Advisory Secretariat evidence-based analyses between 2006 and 2011
2013     Medical Advisory Secretariat (MAS) Transcatheter Aortic Valve Implantation (TAVI) for treatment of aortic valve stenosis: an evidence update
2013     Health Quality Ontario (HQO) Optimizing chronic disease management mega-analysis: economic evaluation
2013     Health Quality Ontario (HQO) How diet challenges are magnified in vulnerable or marginalized people with diabetes and heart disease: a systematic review and qualitative meta-synthesis
2013     Health Quality Ontario (HQO) Chronic disease patients' experiences with accessing health care in rural and remote areas: a systematic review and qualitative meta-synthesis
2013     Health Quality Ontario (HQO) Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis
2013     Health Quality Ontario (HQO) Experiences of patient-centredness with specialized community-based care: a systematic review and qualitative meta-synthesis
2013     Health Quality Ontario (HQO) Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis
2013     Health Quality Ontario (HQO) Electrical stimulation for drug-resistant epilepsy: OHTAC recommendation
2013     Health Quality Ontario (HQO) Carbon-13 urea breath test for Helicobacter pylori infection in patients with uninvestigated ulcer-like dyspepsia: an evidence-based analysis
2013     Health Quality Ontario (HQO) Carbon-13 urea breath test for Helicobacter pylori infection in patients with uninvestigated ulcer-like dyspepsia: OHTAC recommendation
2013     Health Quality Ontario (HQO) Cost-effectiveness of the carbon-13 urea breath test for the detection of Helicobacter pylori: an economic analysis
2013     Health Quality Ontario (HQO) Hysteroscopic tubal sterilization: an evidence-based analysis
2013     Health Quality Ontario (HQO) Hysteroscopic tubal sterilization: OHTAC recommendation
2013     Health Quality Ontario (HQO) Hysteroscopic tubal sterilization: a health economic literature review
2013     Health Quality Ontario (HQO) Vitamin B12 and cognitive function: an evidence-based analysis
2013     Health Quality Ontario (HQO) Vitamin B12 and cognitive function: OHTAC recommendation
2013     Health Quality Ontario (HQO) Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis
2013     Health Quality Ontario (HQO) Deep brain stimulation for treatment-resistant depression: a preliminary evidence review
2013     Health Quality Ontario (HQO) OHTAC recommendation: deep brain stimulation for treatment-resistant depression
2013     Health Quality Ontario (HQO) OHTAC recommendation: endovascular ablation for varicose veins
2013     Health Quality Ontario (HQO) Appropriateness phase 1 OHTAC recommendations: annual health exams, aspartate aminotransferase testing, chloride testing, creatine kinase testing, ferritin testing, folate testing, and vitamin B12 testing
2013     Health Quality Ontario (HQO) OHTAC recommendation: midurethral slings for women with stress urinary incontinence
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with mild cognitive impairment not associated with dementia: a review of diagnostic accuracy, effectiveness and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Mini C-arm imagers for the follow-up of orthopedic patients: clinical effectiveness
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Dressings and care of skin graft sites: a review of clinical evidence and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Drugs for rare diseases: evolving trends in regulatory and health technology assessment perspectives
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal care of chronic, non-healing, lower extremity wounds: a review of clinical evidence and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Copper intra-uterine devices as a contraceptive for adult women: a review of clinical effectiveness and safety
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Naloxone for use in long-term care and palliative care: clinical effectiveness, safety, and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Side rails on beds in long-term and residential care facilities: safety and evidence based guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Interventions for the prevention or management of childhood obesity: a review of the clinical evidence
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Photo-activated disinfection therapy for dental surgery: review of the clinical effectiveness
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Transobturator slings for urinary incontinence: clinical effectiveness and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Antipsychotics for the management of agitation in adults with personality disorders or cognitive impairment: a review of the clinical effectiveness and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Removal of physical restraints in long term care settings: clinical safety and harm
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Heating standards for clinical interventions: clinical evidence
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomography angiography versus computed tomography for the diagnosis and management of hyperacute stroke: a review of comparative clinical evidence and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcendental meditation for posttraumatic stress disorder, depression, and anxiety: a review of clinical effectiveness
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Bioabsorbable stents for adults with coronary artery disease: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) GreenLight laser for the treatment of benign prostatic hypertrophy: a review of clinical and cost-effectiveness, and safety
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Diabetes screening for asymptomatic adults: a review of the diagnostic accuracy, cost effectiveness, and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Management of congestive heart failure in primary and community care: guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Fluconazole administration for the treatment of ductal yeast enfections: clinical effectiveness and safety
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Procedures and tools for patients at risk for creutzfeldt-jakob disease: guidelines and identification
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Nutritional supplementation for patients with cancer: clinical effectiveness and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Nd:YAG laser for the treatment of patients with hidradenitis suppurativa: a review of the clinical effectiveness, cost-effectiveness, and safety
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-surgical debridement for chronic lower extremity wounds: clinical effectiveness and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Abuse and misuse potential of drugs for attention deficit/hyperactivity disorder: a review of the clinical evidence
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Kidney transplantation following cardiocirculatory death: a review of the clinical evidence and guidelines
2013     Technology Assessment Unit of the McGill University Health Centre (MUHC) The effectiveness and safety of rituximab (anti-CD20) in neurologic autoimmune diseases
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-steroidal anti-inflammatory drugs for pain: a review of safety
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Lymphatic-Venous anastomosis for lymphedema: clinical and cost-effectiveness
2013     Technology Assessment Unit of the McGill University Health Centre (MUHC) Transcatheter aortic valve implantation (TAVI) in patients with aortic stenosis. Update of Report No. 45
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tuberculosis testing for correctional staff: diagnostic accuracy and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Prostate cancer screening: a review of the guidelines
2013     Technology Assessment Unit of the McGill University Health Centre (MUHC) Surgical aortic valve replacement with the ATS Enable® sutureless aortic valve for aortic stenosis
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Battery replacement and maintenance of deep brain stimulators: guidelines and recommendations
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Pain management for pediatric patients in the emergency department: guidelines
2013     Technology Assessment Unit of the McGill University Health Centre (MUHC) Renal denervation for resistant hypertension
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Misoprostol administration for the treatment of post-partum uterine atony: clinical effectiveness, safety, and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Bladder instillation of gentamicin for the treatment of recurrent urinary tract infections: clinical evidence and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Routine blood tests for patients in the intensive care unit: clinical effectiveness, cost-effectiveness, and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Swabbing techniques for the detection of bacterial colonization in wounds: comparative clinical evidence and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Long term Use of Clopidogrel for Patients with Stents or Acute Coronary Syndrome: A Review of Clinical and Cost-effectiveness and Guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Management of diabetes in the long-term care population: a review of guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Long term use of clopidogrel for patients with stents or acute coronary syndrome: a review of clinical and cost-effectiveness and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Vaginal preparation prior to cesarean delivery: clinical evidence
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Photo-activated disinfection therapy for non-dental surgery: review of the clinical effectiveness
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Azilsartan Medoxomil + Chlorthalidone (Edarbyclor- Takeda Canada Inc.) indication: severe hypertension
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Hemolysis and blood infusion pumps for patients receiving blood or blood components: standards and evidence-based guidelines: standards and evidence-based guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Technologies assisting in remote consultations for the diagnosis of stroke: a review of the clinical evidence
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Bariatric surgery for obese patients with co-morbidities: a review of clinical effectiveness, cost-effectiveness, and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Appropriateness of CT imaging to support the diagnosis of stroke: a review of the clinical evidence
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) O-Arm technology in spinal, neurological, orthopedic, or trauma surgery settings: clinical effectiveness and benefits and harms to patients and hospital staff
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Linagliptin-metformin (Jentadueto - Boehringer Ingelheim (Canada) Ltd.) indication: type 2 diabetes mellitus
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Intraoperative monitoring during spinal or neurological surgeries: clinical effectiveness and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Perampanel (Fycompa - Eisai Ltd.) indication: epilepsy, partial-onset seizures
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Indigenous knowledge for mental illness and chronic disease: clinical effectiveness and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Azilsartan Medoxomil (Edarbi - Takeda Canada Inc.) indication: mild to moderate essential hypertension
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Management of coronary artery disease in primary and community care: guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Distance consultation for chronic, non-healing, lower extremity wounds: clinical evidence
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Heating standards for magnetic resonance conditional medical devices: clinical evidence
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Plasma vaporization for the treatment of benign prostatic hypertrophy: clinical and cost-effectiveness, and safety
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools compared to parental concern for identifying speech and language delays in preschool children: a review of the diagnostic accuracy
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of surgical masks in the operating room: a review of the clinical effectiveness and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) GreenLight laser for the treatment of benign prostatic hypertrophy: clinical and cost-effectiveness, and safety
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Cleansing of the cervix prior to hysterosalpingogram: clinical evidence and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Community-based programs to improve early childhood health outcomes: guidelines and recommendations
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) CPAP treatment for adults with obstructive sleep apnea: review of the clinical and cost-effectiveness and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-steroidal anti-inflammatory drugs for pain: comparative clinical and cost-effectiveness
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Dressing materials for the treatment of pressure ulcers in patients in long-term care facilities: a review of the comparative clinical effectiveness and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Management of chronic obstructive pulmonary disease in primary and community care: guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Suboxone versus methadone for the treatment of opioid dependence: a review of the clinical and cost-effectiveness
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Comparison of the Ankle Brachial Pressure Index (ABI) doppler with the pocket doppler with plethysmography probe in the assessment of arterial disease in diabetic patients: clinical and cost-effectiveness
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal in-hospital umbilical cord care for newborns: clinical evidence and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Medication administration via metered dose inhalers and aerochambers versus nebulizers for adult patients: clinical effectiveness